ABOUT US
Learn about our Mission, highlights of our unique approach to drug development, and our team.
Learn about our Mission, highlights of our unique approach to drug development, and our team.
PYC’s strategy is to use RNA therapeutics to increase gene expression in haploinsufficient diseases, using proprietary delivery technology to reach target cells. Learn more about our science.
PYC has four development programs focused across three core therapeutic areas – the renal, central nervous and ocular systems. Learn more about our programs.
Patients are at the centre of everything PYC does. Learn more about our clinical trials and other patient resources.
PYC is an ASX listed Company. Access our recent announcements, reports, analyst coverage, posters & publications and governance & policies.